Suppr超能文献

单次血液透析过程中纤溶活性的变化。

Changes in fibrinolytic activity during the course of a single hemodialysis session.

作者信息

Kurz H, Lerner R G, Weseley S, Nelson J C

出版信息

Clin Nephrol. 1985 Jul;24(1):1-4.

PMID:4040447
Abstract

Cardiopulmonary bypass, a form of extracorporeal circulation, markedly increases blood fibrinolytic activity. Accordingly, we measured the effect of hemodialysis, another form of extracorporeal circulation, on fibrinolytic activity in 13 patients with end stage renal disease during and after a single hemodialysis session. Total fibrinolytic activity on fibrin plates, which reflects plasminogen activator levels, was below normal prior to dialysis, rose well above normal at one hour, and then dropped gradually so that just prior to the end of a dialysis session it was still significantly elevated. Within 30 minutes of the end of dialysis, fibrinolytic activity fell rapidly, approaching predialysis levels. In contrast, 5 patients studied before and 3 hours into a peritoneal dialysis session showed no change in their subnormal levels of plasminogen activator. Plasminogen and alpha-2 antiplasmin levels did not change significantly during the course of hemodialysis. Thus, hemodialysis, but not peritoneal dialysis, transiently increases fibrinolytic activity without consuming plasminogen, a pattern consistent with the release of tissue type plasminogen activator.

摘要

体外循环的一种形式——心肺转流术,会显著提高血液纤溶活性。因此,我们测定了另一种体外循环形式——血液透析,对13例终末期肾病患者在单次血液透析期间及透析后的纤溶活性的影响。反映纤溶酶原激活剂水平的纤维蛋白平板上的总纤溶活性,在透析前低于正常水平,在1小时时升至远高于正常水平,然后逐渐下降,以至于在透析即将结束时仍显著升高。透析结束后30分钟内,纤溶活性迅速下降,接近透析前水平。相比之下,5例在腹膜透析前及腹膜透析3小时后接受研究的患者,其低于正常水平的纤溶酶原激活剂水平没有变化。在血液透析过程中,纤溶酶原和α2抗纤溶酶水平没有显著变化。因此,血液透析而非腹膜透析,可短暂提高纤溶活性而不消耗纤溶酶原,这种模式与组织型纤溶酶原激活剂的释放一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验